World Orphan Drug Congress USA 2025
The World Orphan Drug Congress convenes top pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. This conference provides a forum to discuss and advance orphan drug development and enhance access to life-saving therapies for individuals living with a rare disease.
Join us in Boston for three days of the most comprehensive program and inclusive gathering of rare disease stakeholders with over 2,000 attendees, gain insights from top industry leaders, and connect with over 100 exhibitors as we bring together experts across the entire orphan drug lifecycle, discussing areas including regulatory affairs and policy to global pricing and cutting-edge gene therapies.
Our attendees represent the most senior individuals across the industry, including leaders in R&D, gene therapy, rare diseases, precision/personalised medicine, genetic disorders, patient advocacy and engagement, associations in ATMPs, investors, regulatory affairs professions, governmental bodies, and more…
Join the World Orphan Drug Congress USA
🗓️ April 22-24 2025
📍Boston Convention & Exhibition Center | Boston, MA
Follow #WODC on social media to stay up to date 👇
LinkedIn: https://www.linkedin.com/company/world-orphan-drug-congress-usa/
X: @OrphanConf https://x.com/orphanconf
